141 filings
Page 4 of 8
8-K
gg1 ixauy8h
9 May 18
Audentes Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
4:16pm
8-K
e0w58vzxpd8e67
8 May 18
Departure of Directors or Certain Officers
8:05am
DEFA14A
xh9o1ib
27 Apr 18
Additional proxy soliciting materials
12:00am
CT ORDER
5ufzz8rw
23 Apr 18
Confidential treatment order
12:00am
S-3ASR
r7mdz0
29 Mar 18
Automatic shelf registration
12:00am
8-K
4vmrl7l4yehzwzev
8 Mar 18
Audentes Therapeutics Reports Fourth Quarter 2017 and Full Year Financial Results and Provides Corporate Update
12:00am
8-K
zgfx1v3hdk ev2kwrxx1
25 Jan 18
Audentes Therapeutics Announces Pricing of Public Offering of Common Stock
12:00am
424B4
omxpb eukti
25 Jan 18
Prospectus supplement with pricing info
12:00am
S-3MEF
q30pl
24 Jan 18
Registration of additional securities for an S-3
12:00am
8-K
9056mz
23 Jan 18
Results of Operations and Financial Condition
12:00am
424B4
slkidl3nyqh9i5zfb
23 Jan 18
Prospectus supplement with pricing info
12:00am
8-K
6dgkr7k7j brh
4 Jan 18
Regulation FD Disclosure
12:00am
8-K
tjejyo9 4la
13 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
uot9w db58i0e
17 Nov 17
Departure of Directors or Certain Officers
12:00am
S-8
8qwexhwgouf
14 Nov 17
Registration of securities for employees
12:00am
8-K
pvencfvsuh9bb6qn07f
14 Nov 17
Audentes Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update
12:00am